Anhedonia future or investigational therapies

Revision as of 22:40, 19 March 2014 by Pratik Bahekar (talk | contribs)
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

Overview

Even though prevalence of depression is very high, anti-depressant do not work in the 50% of population. The mechanism of all available anti-depressants is same. More research needs to be done to explore new therapies to tackle anhedonia, symptoms of depression and brain function.

Future or Investigational Therapies

Drugs that mimic melanocortin are avaible and they can be tested to relieve symptoms of anhedonia. Clinical studies needs to explore role of melanocortin in the treatment of anhedonia. Treatment of anhedonia can benefit the patients suffering from depression, schizophrenia and terminally ill patients who ave given up hope.[1]


References

  1. "http://med.stanford.edu/ism/2012/july/malenka.html". External link in |title= (help)

Template:WikiDoc Sources